Activation and Blockade of Serotonin-4 Receptors in the Lateral Habenula Produce Antidepressant Effects in the Hemiparkinsonian Rat

Neuropsychobiology. 2021;80(1):52-63. doi: 10.1159/000508680. Epub 2020 Jul 14.

Abstract

Background: The 5-hydroxytryptamine (5-HT) neurotransmitter system and lateral habenula (LHb) are involved in the regulation of depression, while the mechanisms remain to be clarified.

Objectives: The effects and possible mecha-nism underlying activation or blockade of 5-HT4 receptors (5-HT4Rs) in the LHb in depression were investigated by behavioral and neurochemical methods based on a Parkinson's disease (PD) rat model.

Method: 6-Hydroxydopamine (6-OHDA) was injected unilaterally into the substantia nigra pars compacta to establish the PD rat model. The depressive-like behaviors were measured by the forced swimming test (FST) and sucrose preference test (SPT). The concentrations of dopamine (DA), noradrenaline (NA) and 5-HT in the related brain regions were measured by a neurochemical method.

Results: The 6-OHDA lesions increased the immobility time in the FST and decreased the sucrose consumption in the SPT, suggesting the induction of depressive-like behaviors. Intra-LHb injection of BIMU-8 (5-HT4R agonist) or GR113808 (5-HT4R antagonist) produced antidepressant effects in the lesioned rats. Intra-LHb injection of BIMU-8 significantly increased the DA levels in the medial prefrontal cortex (mPFC) and ventral hippocampus (vHip), increased the 5-HT level in the mPFC and decreased the NA level in the vHip only in the lesioned rats, while intra-LHb injection of GR113808 changed DA, NA and 5-HT levels in the mPFC, LHb and vHip in both sham and the lesioned rats.

Conclusions: All these results suggest that activation or blockade of the LHb 5-HT4Rs produce antidepressant effects in the 6-OHDA-lesioned rats, which are related to the changes of monoamines in the limbic and limbic-related regions.

Keywords: 5-HT4 receptors; Depression; Lateral habenula; Parkinson’s disease.

MeSH terms

  • Animals
  • Antidepressive Agents / administration & dosage
  • Antidepressive Agents / pharmacology*
  • Behavior, Animal* / drug effects
  • Behavior, Animal* / physiology
  • Depression* / drug therapy
  • Depression* / etiology
  • Depression* / metabolism
  • Disease Models, Animal
  • Dopamine / metabolism
  • Habenula* / drug effects
  • Habenula* / metabolism
  • Hippocampus* / drug effects
  • Hippocampus* / metabolism
  • Norepinephrine / metabolism
  • Parkinson Disease* / complications
  • Parkinson Disease* / drug therapy
  • Parkinson Disease* / metabolism
  • Prefrontal Cortex* / drug effects
  • Prefrontal Cortex* / metabolism
  • Rats
  • Serotonin / metabolism
  • Serotonin 5-HT4 Receptor Agonists / administration & dosage
  • Serotonin 5-HT4 Receptor Agonists / pharmacology*
  • Serotonin 5-HT4 Receptor Antagonists / administration & dosage
  • Serotonin 5-HT4 Receptor Antagonists / pharmacology*

Substances

  • Antidepressive Agents
  • Serotonin 5-HT4 Receptor Agonists
  • Serotonin 5-HT4 Receptor Antagonists
  • Serotonin
  • Dopamine
  • Norepinephrine